Expression of autocrine motility factor receptor in cutaneous malignant melanoma

Developmental Neuroscience

Volumn 192, Issue 1, 1996, Pages 8-11

  Nagai, Y ^a   Ishikawa, O ^a   Miyachi, Y ^a   Watanabe, Y ^a  

^a GUNMA UNIVERSITY   (Japan)

Author keywords

AMPA receptors; Developing rat brain; Epilepsy; GABAA receptors; Gene expression; Hybridization in situ; Kainic acid; NMDA receptors; Seizures; Silver impregnation

Indexed keywords

AUTOCRINE MOTILITY FACTOR;

ARTICLE; CANCER STAGING; CLINICAL ARTICLE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LYMPH NODE METASTASIS; MELANOMA; MELANOMA CELL; METASTASIS POTENTIAL; PRIORITY JOURNAL;

EID: 0030063910     PISSN: 03785866     EISSN: 14219859     Source Type: Journal    
DOI: 10.1159/000246304     Document Type: Article

References (14)

1. Nicolson GL: Organ specificity of tumor metastasis: Role of preferential adhesion, invasion and growth of malignant cells at specific secondary sites. Cancer Metastasis Rev 1988: 7:143 148.
2. Raz A. Ben Ze'ev A: Cell contact and architecture of malignant cells and their relationship to metastasis. Cancer Metastasis Rev 1987:6: 3-21.
3. Silletti S. Watanabe II. Hogan V. Nabi IR. Raz A: Purification of B16-FI melanoma autocrine motility factor and its receptor. Cancer Res 1991:51:3507-3511.
4. Watanabe H. Carmi P. Hogan V. Raz T. Silletti S. Nabi IR. Raz A: Purification of human tumor cell autocrine motility factor and mole-cularcloning of its receptor. J Biol Chern 1991: 266:13442-13448.
5. Watanabe H. Nabi IR. Raz A: The relationship between motility factor receptor internalization and the lung colonization capacity of murine melanoma cells. Cancer Res 1991:51: 2699-2705.
6. Nabi IR, Watanabe II. Raz, A: Autocrine motility factor and its receptor: Role in cell locomotion and metastasis. Cancer Metastasis Rev 1992:1 1:5-20.
7. Hendrix MCJ. Wood WR, Seftor EA. Lotan D. Nakajima M. Misiorowski R. Seftor REB. Stetlcr-Slcvenson WG. Bcracqua SJ. Liotta LA. Sobel ME. Raz A. Lotan R: Retinoic acid inhibition of human melanoma cell invasion through a reconstituted basement membrane and its relation to decreases in the expression of proteolytic enzymes and motility factor receptor. Cancer Res 1990:50:4121-4130.
8. Lotan R. Amos B. Watanabe H. Raz A: Suppression of melanoma cell motility factor receptor expression by retinoic acid. Cancer Res 1992:52:4878-4884.
9. Watanabe H. Shinosaka T. Raz A. Chigira M: Expression of autocrine motility factor receptor in scrum- and protein-independent fibrosarcoma cells: Implications for autonomy in tumor-cell motility and metastasis. Ini J Cancer 1993:53:689-695.
10. Clark WH Jr. From L. Bernardino EA, Mihm MC: The histogenesis and biologic behavior of primary human malignant melanomas of the skin. Cancer Res 1969:29:705-726.
11. Breslow A: Thickness, cross-sectional areas and depth of invasion in the prognosis of cutaneous melanoma. Ann Surg 1970:172: 902-908.
12. Hakomori S: Aberrant glycosylation in tumors and tumor-associated carbohydrate antigens. Adv Cancer Res 1989:52:257-331.
13. Otto T. Birchmeier W. Schmidt U. Hinke A. Schippcr J. Rubben H. Raz A: Inverse relation of E-cadherin and autocrine motility factor receptor expression as a prognostic factor in patients with bladder carcinomas. Cancer Res 1994:54:3120-3123.
14. Nakaniori S. Watanabe H. Kamcyama M. Ima-oka S. Furukawa H. Ishikawa O. Sasaki Y, Kabut T. Raz A: Expression of autocrine motility factor receptor in colorectal cancer as a predictor for disease recurrence. Cancer 1994: 74:1855-1862.